Achondroplasia and severe sensorineural hearing loss: The role of active bone conduction implants

The BONEBRIDGE is a partially implantable, transcutaneous bone conduction device that can be used to treat conductive or mixed mild-to-moderate hearing loss in patients who do not attain sufficient improvement from conventional hearing aids. The following case report describes sequential bilateral B...

Full description

Saved in:
Bibliographic Details
Published in:Cochlear implants international 2022-09, Vol.23 (5), p.1-299
Main Authors: Siegel, Lauren, Araslanova, Rakhna, Stepniak, Camilla, Zimmerman, Kim, Agrawal, Sumit K
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The BONEBRIDGE is a partially implantable, transcutaneous bone conduction device that can be used to treat conductive or mixed mild-to-moderate hearing loss in patients who do not attain sufficient improvement from conventional hearing aids. The following case report describes sequential bilateral BONEBRIDGE implantation in a 25-year-old patient with achondroplasia and bilateral mixed-hearing loss with a significant sensorineural component in the setting of chronic suppurative otitis media. Although the patient did not meet the approved BONEBRIDGE criteria, implantation was successful with improvements in audiological outcomes and self-reported quality of life. There were no reported complications at 5-years post-implantation.
ISSN:1467-0100
1754-7628
DOI:10.1080/14670100.2022.2045073